Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia

Japanese Journal of Cancer Research

Volumn 88, Issue 8, 1997, Pages 770-777

  Masunaga, Shin Ichiro ^a   Ono, Koji ^a   Akaboshi, Mitsuhiko ^b   Kawai, Ken Ichi ^b   Suzuki, Minoru ^a   Kinashi, Yuko ^a   Takagaki, Masao ^a  

^a Radiat Oncology Research Laboratory   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

cis Diamminedichloroplatinum (II); Hyperthermia; Hypoxic cells; Nicotinamide; Quiescent cell

Indexed keywords

BROXURIDINE; CISPLATIN; NICOTINAMIDE; PLATINUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL SUSPENSION; CHEMOSENSITIVITY; CONTROLLED STUDY; HYPERTHERMIC THERAPY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR BLOOD FLOW;

EID: 0030775057     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00449.x     Document Type: Article

References (30)

1. Jackson, R. C. The problem of the quiescent cancer cells. Adv. Enzyme Regul., 29, 27-46 (1989).
2. Steel, G. G. Cell population kinetics of tumours in experimental animals. In "Growth Kinetics of Tumours," ed. G. G. Steel, pp. 146-216 (1977). Clarendon Press, Oxford.
3. Hermens, A. F. and Barendsen, G. W. The proliferative status and clonogenic capacity of tumor cells in a transplantable rhabdomyosarcoma of the rat before and after irradiation with 800 rad of X-rays. Cell Tissue Kinet., 11, 83-100 (1978).
4. Overgaard, J. Sensitization of hypoxic tumor cells - clinical experience. Int. J. Radiat. Biol., 56, 801-811 (1989).
5. Kjellen, E., Joiner, M. C., Collier, J. M., Johns, H. and Rojas, A. A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother. Oncol., 22, 81-91 (1991).
6. Overgaard, J. and Horsman, M. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin. Radiat. Oncol., 6, 10-21 (1996).
7. Overgaard, J., Gonzales, D. G., Hulshor, M. C. C. M., Archangeli, G., Dahl, O., Mella, O. and Bentzen, S. M. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet, 345, 540-543 (1995).
8. Vaupel, P. Pathological mechanisms of hyperthermia in cancer therapy. In "Biological Basis for Oncologic Thermotherapy," ed. M. Gautherie, pp. 73-134 (1990). Springer-Verlag, Heidelberg.
9. Dewey, W. C. Arrhenius relationship from the molecule and cell to clinic. Int. J. Hyperthermia, 10, 457-483 (1994).
10. Valdagni, R., Liu, F.-F. and Kapp, D. S. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int. J. Radiat. Oncol. Biol. Phys., 15, 959-972 (1988).
11. Oleson, J. R., Samulski, T. V., Leopard, K. A., Clegg, S. T., Dewhirst, M. W., Dodge, R. K. and George, S. L. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int. J. Radiat. Oncol. Biol. Phys., 25, 289-297 (1993).
12. Oleson, J. R. Hyperthermia from the clinic to the laboratory: hypothesis (Eugene Robinson Special Lecture). Int. J. Hyperthermia, 11, 315-322 (1995).
13. Masunaga, S., Ono, K. and Abe, M. A method for selective measurement of the radiosensitivity of quiescent cells in solid tumors - combination of immunofluorescence staining to BrdU and micronucleus assay. Radiat. Res., 125, 243-247 (1991).
14. Horsman, M., Chaplin, D. J. and Brown, J. M. Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. Radiat. Res., 118, 139-150 (1989).
15. Nishimura, Y., Shibamoto, Y., Jo, S., Akuta, K., Hiraoka, M., Takahashi, M. and Abe, M. Relationship between heat-induced vascular damage and thermosensitivity in four mouse tumors. Cancer Res., 48, 7226-7230 (1988).
16. Ono, K., Wandl, E. O., Tsutsui, K., Sasai, K. and Abe, M. The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency. Strah-lenther. Onkol., 165, 824-827 (1989).
17. Mitchell, J., Morstyn, G., Russo, A., Kinsella, T., Fornance, A., McPherson, S. and Glatstein, E. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. Int. J. Radiat. Oncol. Biol. Phys., 10, 1447-1451 (1984).
18. Fenech, M. and Morley, A. A. Measurement of micronuclei in lymphocytes. Mutat. Res., 147, 29-36 (1985).
19. Akaboshi, M., Kawai, K., Kinashi, Y., Masunaga, S. and Ono, K. Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in Hela cells treated with cis-diammine(glycolato)platinum(II). Jpn. J. Cancer Res., 87, 522-526 (1996).
20. 195mPt radiolabeled cis-diamminedichloroplatinum(II) of high chemical and radiochemical purity using high performance liquid chromatography. J. Radioanal. Nucl. Chem. Lt., 136, 67-74 (1989).
21. Dethlefsen, L. A. In quest of the quaint quiescent cells. In "Radiation Biology in Cancer Research," ed. E. Meyn and H. Withers, pp. 3-20 (1980). Raven Press, New York.
22. Lee, I., Boucher, Y. and Jain, R. K. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res., 52, 3237-3240 (1992).
23. Secomb, T. W., Hsu, R., Ong, E. T., Gross, J. F. and Dewhirst, M. W. Analysis of the effect of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol., 34, 313-316 (1995).
24. 2 can be increased markedly by mild hyperthermia. Br. J. Cancer, 74 (Suppl. XXVII), S217-S221 (1996).
25. Song, C. W., Shakil, A., Osborn, J. L. and Iwata, K. Tumor oxygenation is increased by hyperthermia at mild temperatures. Int. J. Hyperthermia, 12, 367-373 (1996).
26. Masunaga, S., Ono, K. and Abe, M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours. Br. J. Radiol., 66, 918-926 (1993).
27. Kallinowski, F., Schlenger, K. H., Runkel, S., Kloes, S., Stohrer, M., Okunnieff, P. and Vaupel, P. Blood flow, metabolism, cellular microenvironment and growth rate of human tumor xenografts. Cancer Res., 49, 3759-3764 (1989).
28. Jain, R. K. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst., 81, 570-576 (1989).
29. Fenton, B. M. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCC VII and KHT murine tumours. Br. J. Cancer, 71, 945-949 (1995).
30. Nishimura, Y., Ono, K., Hiraoka, M., Masunaga, S., Jo, S., Shibamoto, Y., Sasai, K., Abe, M., Iga, K. and Ogawa, Y. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat. Res., 122, 161-167 (1990).